Quinoxalin-2-amine

Catalog No. :
ACWBHY604
CAS No. :
5424-05-5
Molecular Formula :
C8H7N3
Molecular Weight :
145.16

IUPAC Name:quinoxalin-2-amine

Quinoxalin-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$71.00Login to see priceIn stockIn stock
5g97%$245.00Login to see priceIn stockIn stock
25g97%$904.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameQuinoxalin-2-amine
IUPAC Namequinoxalin-2-amine
MDL No.MFCD00094018
Molecular FormulaC8H7N3
Molecular Weight145.16
SMILESNC1=NC2=C(C=CC=C2)N=C1
InChI KeyYOWAEZWWQFSEJD-UHFFFAOYSA-N
SynonymEN300-97442 | BDBM92286 | AS-19969 | 2-(methylthio)-4,5-bis[N-(2-propyl) carbonyloxymethyl]imidazole | Z979455432 | doi:10.14272/YOWAEZWWQFSEJD-UHFFFAOYSA-N.1 | SY076122 | 2-Quinoxalinamine | NSC-13155 | 2-Quinoxalinamine # | CCG-321211 | DTXSID00279557 |
CAS No.5424-05-5
PubChem CID224573

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACWBHY604 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJGNF798 route compound structure diagram
    ACJGNF7981448-87-9 In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACWBHY604 route product structure diagram
    ACWBHY6045424-05-5 In Stock
Inquiry

2. ACWBHY604 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBCRN096 route compound structure diagram
    ACBCRN09622840-91-1 In Stock
  2. Plus
  3. ACJGNF798 route compound structure diagram
    ACJGNF7981448-87-9 In Stock
  4. Plus
  5. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  6. Then
  7. ACWBHY604 route product structure diagram
    ACWBHY6045424-05-5 In Stock
Inquiry

Comments (0)